Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare Services Industry Analysis

UpdatedOct 03, 2025
DataAggregated Company Financials
Companies161
  • 7D2.9%
  • 3M6.6%
  • 1Y-20.6%
  • YTD-6.7%

In the last week, the Healthcare Services industry is up 2.9%, with UnitedHealth Group up 2.4%. During this same period, the HealthEquity underperformed, falling 6.7%. In the past year, the industry is down 21%. As for the next few years, earnings are expected to grow by 13% per annum.

Industry Valuation and Performance

Has the U.S. Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 03 Oct 2025US$905.3bUS$2.1tUS$49.3b21.4x18.4x0.4x
Sun, 31 Aug 2025US$859.7bUS$2.1tUS$49.3b21.5x17.4x0.4x
Tue, 29 Jul 2025US$790.0bUS$2.1tUS$50.8b20x15.5x0.4x
Thu, 26 Jun 2025US$875.8bUS$2.1tUS$52.7b22.1x16.6x0.4x
Sat, 24 May 2025US$856.0bUS$2.1tUS$52.5b19.2x16.3x0.4x
Mon, 21 Apr 2025US$956.8bUS$1.7tUS$49.4b23.1x19.4x0.6x
Wed, 19 Mar 2025US$1.0tUS$1.7tUS$41.5b23.9x24.3x0.6x
Fri, 14 Feb 2025US$1.0tUS$1.7tUS$41.1b23.9x25x0.6x
Sun, 12 Jan 2025US$1.0tUS$2.0tUS$42.2b21.6x24.5x0.5x
Tue, 10 Dec 2024US$1.1tUS$2.0tUS$41.4b23.7x26.3x0.6x
Thu, 07 Nov 2024US$1.1tUS$1.9tUS$44.0b25.7x25.6x0.6x
Sat, 05 Oct 2024US$1.2tUS$1.9tUS$43.3b24.5x27.4x0.6x
Mon, 02 Sep 2024US$1.2tUS$1.9tUS$43.3b26.6x28.3x0.6x
Wed, 31 Jul 2024US$1.2tUS$1.9tUS$43.3b27.7x27.5x0.6x
Fri, 28 Jun 2024US$1.1tUS$1.9tUS$43.4b24.3x25x0.6x
Sun, 26 May 2024US$1.1tUS$1.9tUS$43.3b26.5x25.2x0.6x
Tue, 23 Apr 2024US$1.1tUS$1.9tUS$43.0b25.9x25.9x0.6x
Thu, 21 Mar 2024US$1.1tUS$1.8tUS$49.7b24.5x22.7x0.6x
Sat, 17 Feb 2024US$1.1tUS$1.8tUS$49.9b25.4x23x0.6x
Mon, 15 Jan 2024US$1.2tUS$1.8tUS$50.8b24x22.7x0.6x
Wed, 13 Dec 2023US$1.2tUS$1.8tUS$51.2b23.3x22.9x0.7x
Fri, 10 Nov 2023US$1.1tUS$1.8tUS$50.5b20.8x22.8x0.6x
Sun, 08 Oct 2023US$1.1tUS$1.8tUS$46.9b22.4x24x0.6x
Tue, 05 Sep 2023US$1.1tUS$1.8tUS$46.7b22.2x23x0.6x
Thu, 03 Aug 2023US$1.1tUS$1.8tUS$47.4b22.4x24.1x0.7x
Sat, 01 Jul 2023US$1.1tUS$1.7tUS$46.1b23.6x23.9x0.6x
Mon, 29 May 2023US$1.1tUS$1.7tUS$45.7b21.6x23.5x0.6x
Wed, 26 Apr 2023US$1.1tUS$1.4tUS$44.3b23.8x24.2x0.7x
Fri, 24 Mar 2023US$1.0tUS$1.4tUS$44.4b21.6x23.2x0.7x
Sun, 19 Feb 2023US$1.1tUS$1.4tUS$43.5b22.5x26.2x0.8x
Tue, 17 Jan 2023US$1.1tUS$1.4tUS$45.0b21.4x25.2x0.8x
Thu, 15 Dec 2022US$1.2tUS$1.4tUS$44.4b21x27.3x0.9x
Sat, 12 Nov 2022US$1.2tUS$1.4tUS$44.5b20.1x26.4x0.8x
Mon, 10 Oct 2022US$1.1tUS$1.4tUS$46.1b19x24.6x0.8x
Price to Earnings Ratio

24.6x


Total Market Cap: US$1.1tTotal Earnings: US$46.1bTotal Revenue: US$1.4tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Services Industry Price to Earnings3Y Average 23.6x202320242025
Current Industry PE
  • Investors are pessimistic on the American Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 18.4x which is lower than its 3-year average PE of 23.6x.
  • The industry is trading close to its 3-year average PS ratio of 0.62x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 2.3% per year over the last three years.
  • Revenues for these companies have grown 15% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market1.62%
Healthcare6.37%
Healthcare Services2.87%
Healthcare Services2.98%
Healthcare Distributors2.89%
Managed Healthcare2.87%
Healthcare Facilities2.43%
Industry PE
  • Investors are most optimistic about the Healthcare Distributors industry even though it's trading below its 3-year average PE ratio of 37.9x.
    • Analysts are expecting annual earnings growth of 13.7%, which is higher than its past year's earnings growth of 6.3% per year.
  • Investors are most pessimistic about the Managed Healthcare industry, which is trading below its 3-year average of 22.3x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 20% over the next 5 years.
  • This is better than its past earnings decline of 0.03% per year.
  • In contrast, the Managed Healthcare industry is expected to see its earnings grow by 7.8% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
UNH UnitedHealth GroupUS$353.722.4%
+US$7.4b		-40.3%PE15x
ELV Elevance HealthUS$340.247.4%
+US$5.3b		-31.7%PE14.3x
CVS CVS HealthUS$77.453.8%
+US$3.6b		23.1%PE21.7x
CI Cigna GroupUS$296.984.5%
+US$3.4b		-12.8%PE15.8x
HCA HCA HealthcareUS$426.692.8%
+US$2.8b		8.7%PE16.7x

Latest News

UNH
US$353.72
UnitedHealth Group
7D
2.4%
1Y
-40.3%
ALHC
US$16.05
Alignment Healthcare
7D
-7.3%
1Y
47.7%
ELV
US$340.24
Elevance Health
7D
7.4%
1Y
-31.7%
CRVL
US$73.41
CorVel
7D
-6.4%
1Y
-29.4%
CHE
US$442.04
Chemed
7D
-1.9%
1Y
-24.5%
DGX
US$180.96
Quest Diagnostics
7D
-2.4%
1Y
19.0%
HQY
US$89.68
HealthEquity
7D
-6.7%
1Y
14.7%
CAH
US$158.46
Cardinal Health
7D
6.4%
1Y
43.6%
EHC
US$123.55
Encompass Health
7D
-1.6%
1Y
30.4%
MCK
US$758.70
McKesson
7D
3.0%
1Y
57.3%

Pharmaceutical Demand And Digital Automation Will Shape Future Markets

McKesson’s fair value saw only a marginal increase as analyst expectations for both revenue growth and net profit margin remained virtually unchanged, with the target price moving slightly from $788.57 to $793.21. What's in the News Playhouse MD™, a pediatric healthcare brand, has entered a strategic distribution alliance with McKesson Medical-Surgical, making its products available nationwide and expanding McKesson's portfolio in pediatric care.
HCA
US$426.69
HCA Healthcare
7D
2.8%
1Y
8.7%

Expanding Healthcare Services And Capital Allocation Will Yield Value

HCA Healthcare’s consensus price target has risen as analysts factor in positive impacts from newly approved Texas payments and strong margins despite softening volumes, reflecting management’s resilience in adapting to policy challenges, with fair value increasing from $398.57 to $403.81. Analyst Commentary Incorporation of preliminary estimates for newly approved state-directed payments in Texas driving upward revisions in price targets.
CVS
US$77.45
CVS Health
7D
3.8%
1Y
23.1%
CLOV
US$2.53
Clover Health Investments
7D
-19.9%
1Y
-36.8%
COR
US$308.57
Cencora
7D
3.3%
1Y
39.6%
PGNY
US$20.55
Progyny
7D
-3.8%
1Y
29.9%

Rising Demand For Women's Health Will Transform Market Opportunity

Analysts cite improving membership trends, positive pre-announcements, and strategic partnerships expanding Progyny's women's health services as driving renewed confidence and modest upgrades, though the consensus price target remains unchanged at $28.25. Analyst Commentary Bullish analysts cite a rebound in membership activity, highlighted by two consecutive positive pre-announcements, as signaling recovery from last year's lows and renewed momentum.
CI
US$296.98
Cigna Group
7D
4.5%
1Y
-12.8%